Single-domain antibodies for biomedical applications

被引:56
作者
Krah, Simon [1 ]
Schroeter, Christian [1 ]
Zielonka, Stefan [2 ]
Empting, Martin [3 ]
Valldorf, Bernhard [2 ]
Kolmar, Harald [2 ]
机构
[1] Merck KGaA, Merck Serono, Prot Engn & Antibody Technol, Darmstadt, Germany
[2] Tech Univ Darmstadt, Inst Organ Chem & Biochem, Alarich Weiss Str 4, D-64287 Darmstadt, Germany
[3] Univ Saarland, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Drug Design & Optimizat, D-66123 Saarbrucken, Germany
关键词
VHH; heavy chain antibody; Antibody engineering; antibody fragment; single chain binding domain; IgNAR; SHARK IGNAR ANTIBODY; ANTIGEN RECEPTOR IGNAR; VARIABLE DOMAINS; BIOPHYSICAL PROPERTIES; AFFINITY MATURATION; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; SELECTION; FRAGMENTS; NANOBODY;
D O I
10.3109/08923973.2015.1102934
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Single-domain antibodies are the smallest antigen-binding units of antibodies, consisting either only of one variable domain or one engineered constant domain that solely facilitates target binding. This class of antibody derivatives comprises naturally occurring variable domains derived from camelids and sharks as well as engineered human variable or constant antibody domains of the heavy or light chain. Because of their high affinity and specificity as well as stability, small size and benefit of multiple re-formatting opportunities, those molecules emerged as promising candidates for biomedical applications and some of these entities have already proven to be successful in clinical development.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 114 条
[81]   Anticalins: Exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins [J].
Richter, A. ;
Eggenstein, E. ;
Skerra, A. .
FEBS LETTERS, 2014, 588 (02) :213-218
[82]   Isolation of antigen-binding camelid heavy chain antibody fragments (nanobodies) from an immune library displayed on the surface of Pichia pastoris [J].
Ryckaert, Stefan ;
Pardon, Els ;
Steyaert, Jan ;
Callewaert, Nico .
JOURNAL OF BIOTECHNOLOGY, 2010, 145 (02) :93-98
[83]   Shark IgNAR antibody mimotopes target a murine immunoglobulin through extended CDR3 loop structures [J].
Simmons, David P. ;
Streltsov, Victor A. ;
Dolezal, Olan ;
Hudson, Peter J. ;
Coley, Andrew M. ;
Foley, Michael ;
Proll, David F. ;
Nuttall, Stewart D. .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2008, 71 (01) :119-130
[84]   Dimerisation strategies for shark IgNAR single domain antibody fragments [J].
Simmons, David P. ;
Abregu, Fiona A. ;
Krishnan, Usha V. ;
Proll, David F. ;
Streltsov, Victor A. ;
Doughty, Larissa ;
Hattarki, Meghan K. ;
Nuttall, Stewart D. .
JOURNAL OF IMMUNOLOGICAL METHODS, 2006, 315 (1-2) :171-184
[85]   Nanobodies as novel agents for disease diagnosis and therapy [J].
Siontorou, Christina G. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2013, 8 :4215-4227
[86]   DOMAIN LIBRARIES - SYNTHETIC DIVERSITY FOR DE-NOVO DESIGN OF ANTIBODY V-REGIONS [J].
SODERLIND, E ;
VERGELES, M ;
BORREBAECK, CAK .
GENE, 1995, 160 (02) :269-272
[87]   Crystal structure of a shark single-domain antibody V region in complex with lysozyme [J].
Stanfield, RL ;
Dooley, H ;
Flajnik, MF ;
Wilson, IA .
SCIENCE, 2004, 305 (5691) :1770-1773
[88]   Maturation of shark single-domain (IgNAR) antibodies: Evidence for induced-fit binding [J].
Stanfield, Robyn L. ;
Dooley, Helen ;
Verdino, Petra ;
Flajnik, Martin F. ;
Wilson, Ian A. .
JOURNAL OF MOLECULAR BIOLOGY, 2007, 367 (02) :358-372
[89]   Structural evidence for evolution of shark Ig new antigen receptor variable domain antibodies from a cell-surface receptor [J].
Streltsov, VA ;
Varghese, JN ;
Carmichael, JA ;
Irving, RA ;
Hudson, PJ ;
Nuttall, SD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (34) :12444-12449
[90]   Structure of a shark IgNAR antibody variable domain and modeling of an early-developmental isotype [J].
Streltsov, VA ;
Carmichael, JA ;
Nuttall, SD .
PROTEIN SCIENCE, 2005, 14 (11) :2901-2909